echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature discovers new cell type with regenerative properties in human lungs

    Nature discovers new cell type with regenerative properties in human lungs

    • Last Update: 2022-04-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Figure: Human ES cell-derived RASCs (respiratory airway secretory cells, which are gradually transformed into alveolar type 2 cells during culture)


    Researchers at the Perelman School of Medicine at the University of Pennsylvania have discovered a new type of cell located deep in the human lung that may play a key role in human lung disease


    The researchers, reporting their findings today in the journal Nature, analyzed human lung tissue to identify new cells, which they termed airway secretory cells (RASCs)


    "COPD is a devastating common disease, but we really don't understand the cell biology of why or how some patients develop it


    Chronic obstructive pulmonary disease is typically characterized by progressive damage and loss of alveoli, exacerbated by chronic inflammation


    In the new study, Morrissey and his team found evidence of RASCs when examining the signature of gene activity in lung cells from healthy human donors


    "With studies like this we're starting to understand, at the cellular biology level, what's really going on in this very common disease," said senior author Edward Morrisey, Ph.


    By looking at similarities in gene activity between RASCs and AT2 cells, an important progenitor cell in the alveoli, the team made further discoveries: RASCs, in addition to their secretory function, also act as AT2 cell precursors -- enabling AT2 cells to regenerate to Maintain the number of AT2 cells and keep the alveoli healthy


    AT2 cells are known to become abnormal in COPD and other lung diseases, and the researchers found that defects in RASCs may be an upstream cause of these abnormalities


    More research is needed, but these findings suggest that future COPD treatments may work by restoring normal RASC-at2 differentiation processes, or even by replenishing the normal RASC population in damaged lungs, Morrisey said


    article title

    Human distal airways contain a multipotent secretory cell that can regenerate alveoli


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.